Vanguard Investments Australia
TYRA icon

Vanguard Investments Australia’s Tyra Biosciences TYRA Stock Holding History

Vanguard Investments Australia’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Buy
7,349
+4,421
+151% +$146K ﹤0.01% 2046
2026
Q1 		$112K Buy
+2,928
New +$94.8K ﹤0.01% 2254

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Investments Australia's TYRA Position: Q2 2026 in Review

Vanguard Investments Australia increased its Tyra Biosciences (TYRA) stake by 151% in Q2 2026, buying an estimated $146K and bringing the position to 7,349 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #2046.

Vanguard Investments Australia first reported a position in TYRA in Q1 2026 and has held it in 2 quarters since. 155 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Vanguard Investments Australia held 7,349 shares of Tyra Biosciences worth $235K as of Q2 2026.
  • Vanguard Investments Australia bought 4,421 Tyra Biosciences shares in Q2 2026, an estimated $146K.
  • Tyra Biosciences made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #2046 holding.
  • Vanguard Investments Australia first reported a position in Tyra Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.